Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artificial cells in hemoperfusion and other applications.

T M Chang

    Nephron
    |January 1, 1984
    PubMed
    Summary

    This paper reviews the current status of artificial cells in medical applications. It discusses their potential use in treating acute intoxication, supporting organ functions like the kidney and liver, and acting as enzyme replacements. The authors suggest that artificial cells may also function as red blood cell substitutes and immunosorbents. The study emphasizes the need for further research to clarify their clinical effectiveness and design. It highlights the ongoing development of artificial cell technologies for various therapeutic purposes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does conventional early life academic excellence predict later life scientific discovery? An assessment of the lives of great medical innovators.

    QJM : monthly journal of the Association of Physicians·2020
    Same author

    Propentdyopent: the scaffold of a heme metabolite as an electron reservoir in transition metal complexes.

    Chemical communications (Cambridge, England)·2016
    Same author

    Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver.

    Oncogene·2013
    Same author

    Microencapsulation of enzymes, cells, and genetically engineered microorganisms.

    Methods in molecular medicine·2011
    Same author

    Structure and dynamics of N,N-diethyl-N-methylammonium triflate ionic liquid, neat and with water, from molecular dynamics simulations.

    The journal of physical chemistry. A·2010
    Same author

    Neurohormonal control of exocrine pancreas.

    Current opinion in gastroenterology·2006

    Area of Science:

    • Artificial cell development in biomedical engineering
    • Hemoperfusion techniques in clinical toxicology

    Background:

    Current research has explored artificial cells as tools for various medical applications. Prior studies have demonstrated their potential in managing acute intoxication and supporting organ function. However, gaps remain in understanding their full clinical utility. No prior work has resolved the specific mechanisms of artificial cells in hemoperfusion. This uncertainty drives further investigation into their design and application. Artificial cells have been proposed for use in artificial kidneys and livers. Their role in enzyme replacement therapies has also been suggested. This paper aims to clarify the current status of artificial cells across multiple fields.

    Purpose Of The Study:

    The authors aim to evaluate the present status of artificial cells in medical applications. They focus on their use in treating acute intoxication and supporting organ functions. The study addresses gaps in understanding how artificial cells operate in hemoperfusion. It also explores their potential in enzyme replacement and immunosorbent roles. The authors seek to synthesize current evidence on artificial cell applications. They highlight the need for further research into their clinical effectiveness. This work provides a review of artificial cell technologies in diverse medical contexts. The study emphasizes the importance of clarifying their current limitations.

    Keywords:
    artificial cell technologyhemoperfusion applicationsbiomedical engineeringorgan support systems

    Frequently Asked Questions

    Artificial cells may be used in hemoperfusion to manage acute intoxication by removing toxins from the blood.

    Artificial cells may mimic red blood cells by carrying oxygen and delivering it to tissues.

    Hemoperfusion is considered for acute intoxication because it can rapidly remove toxins from the bloodstream.

    Artificial cells may deliver enzymes to replace those lacking in patients with metabolic disorders.

    Related Experiment Videos

    Main Methods:

    The authors conducted a review of existing literature on artificial cells. They examined applications in acute intoxication and organ support systems. The study included an analysis of artificial kidney and liver technologies. They also considered the role of artificial cells in immunosorbent therapies. The review approach involved synthesizing findings from multiple sources. The authors evaluated the status of artificial cells in enzyme replacement. They compared different types of artificial cells and their functions. The study did not introduce new experimental data but summarized current knowledge.

    Main Results:

    The review suggests artificial cells are used in hemoperfusion for acute intoxication. They may serve as artificial kidneys and livers in clinical settings. The study indicates artificial cells can act as red blood cell substitutes. They may also function as immunosorbents to remove toxins. The authors report on enzyme replacement applications of artificial cells. Their findings suggest artificial cells have potential in diverse medical areas. The review highlights the current status of artificial cell technologies. It proposes further research to clarify their clinical effectiveness.

    Conclusions:

    The authors conclude that artificial cells have multiple potential applications. They suggest these cells may support organ functions and detoxification. The study emphasizes the need for further research into artificial cell design. It proposes that artificial cells could replace natural cells in certain therapies. The authors highlight their role in enzyme replacement and immunosorbent functions. They suggest artificial cells may improve hemoperfusion outcomes. The review concludes that artificial cells are promising but require more study. Their current status reflects ongoing development in biomedical engineering.

    Artificial cells may perform similar functions to natural cells but are designed for specific therapeutic purposes.

    Artificial cells are in development for various applications, including organ support and detoxification therapies.